Refractory Spontaneous #Pneumothorax in #InterstitialLungDisease Under #Pirfenidone Treatment
onlinelibrary.wiley.com/doi/10.1002/...

🔴 #ERSCongress
Étude des modifications pharmacocinétiques induites par le #nérandomilast sur la #pirfenidone et le #nintédanib : le nérandomilast ne semble pas modifier la pharmacocinétique du nintedanib ni de la pirfenidone.
#OrphaLung
#FPI #IPF #ILD

🔴 #ERSCongress
Présentation de #Combi-pf concernant la combinaison des deux #antifibrosants disponibles : #ninténanib et #pirfenidone. ⚠️ Point de vigilance sur la majoration des symptômes digestifs !
#OrphaLung.

📣 EDITOR'S CHOICE for the Respirology August issue:
Add-On #Dextromethorphan Improves the Effects of #Pirfenidone in #Bleomycin-Treated Mice and Patients With #PulmonaryFibrosis
onlinelibrary.wiley.com/doi/10.1111/...

#Rituximab and #Pirfenidone in the Treatment of Steroid-Refractory #Bleomycin #LungInjury
onlinelibrary.wiley.com/doi/10.1002/...

Synapse - referral | European Medicines Agency (EMA) Synapse Labs Pvt. Ltd: re-examination confirms suspension of medicines over flawed studies On 21 March 2024, EMA’s human medicines committee (CHMP) confirmed its recommendation to suspend or not grant...

⚠️Consumer Watch Recall/Advisory Alert⚠️ Medication: 👇🏼
Accel-Ondansetron ODT, Mint-Betahistine, PMS-irfenidone Tablets

#Recall #PirfenidoneTablets #Pirfenidone #Advisory #MedicationRecall #Pharmacists #Pharmacy #SerotoninSyndrome #RecallAlert #AdvisoryAlert #MedicationAlert #Pills #Prescription

Prolonged-release pirfenidone shows promise in compensated liver cirrhosis Prolonged-release pirfenidone given every 12 hours at 1200 mg/day significantly improves liver function compared with placebo in patients with compensated liver cirrhosis.

#MedNews - Prolonged-release #pirfenidone given every 12 hours at 1200 mg/day significantly improves liver function compared with placebo in patients with compensated #LiverCirrhosis.

Full story 👉 buff.ly/sxelCsb

#GastroSky #Hepatology

#Medsky🧪 #IDsky #pharmsky #publichealth The study founded #Pirfenidone doesn’t significantly reduce the proportion of patients with #postCOVID fibrotic changes after 6 months of treatment . FVC % improvement and % HRCT fibrotic reduction with pirfenidone were not statistically different from placebo

Long COVID Web: April 2025 Webinar #MECFS #LongCovid #Upadacitinib #Pirfenidone

youtu.be/O0gkidDSxaw?...

Add-On #Dextromethorphan Improves the Effects of #Pirfenidone in #Bleomycin-Treated Mice and Patients With #Pulmonary #Fibrosis
onlinelibrary.wiley.com/doi/10.1111/...